Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.
Clinical trial NCT03136666 · COMPLETED
Trial details
- NCT number
- NCT03136666
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-19
- Primary completion
- 2010-06-07
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.